Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q3 2023 · 10-Q
Revenue$629.91K$629.91K+1,865.4% vs Q3 2022 Net Income-$3.47M-$3.47MN/M vs Q3 2022 EPS Diluted-$0.20-$0.20N/M vs Q3 2022 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,940,259N/M Free Cash Flowderived-$3,079,550N/M Margins · derivedGross margin38.7%+58.7 pt vs Q3 2022
Operating margin-557.3%+8059.0 pt vs Q3 2022
Net margin-550.7%+8060.3 pt vs Q3 2022
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end